Denmark wants EU to take another look at NSAID safety
This article was originally published in SRA
Executive Summary
Denmark’s drug regulator is seeking a further European Union review of the cardiovascular risks associated with non-steroidal anti-inflammatory drugs after a pharmaco-epidemiological study in an apparently healthy Danish population found an increased risk of heart attack or death not only in users of selective COX-2 inhibitors but in people taking over-the-counter painkillers such as diclofenac1.